TD Cowen assumed coverage on shares of Beauty Health ( NASDAQ:SKIN – Free Report ) in a report published on Friday morning,Zacks reports. The brokerage issued a hold rating on the stock.
A number of other research analysts also recently issued reports on SKIN. Zacks Research downgraded shares of Beauty Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 20th. Jefferies Financial Group reaffirmed a “hold” rating and set a $11.00 target price (up from $0.85) on shares of Beauty Health in a research report on Monday, October 19th. Stifel Nicolaus set a $10.00 price target on shares of Beauty Health in a report on Thursday, October 15th. Canaccord Genuity Group set a $11.00 price objective on Beauty Health and gave the stock a “hold” rating in a research note on Thursday, October 22nd. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of Beauty Health in a research note on Wednesday, October 21st. One equities research analyst has rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Beauty Health currently has an average rating of “Hold” and a consensu...